Toparlak Ö Duhan, Zasso Jacopo, Bridi Simone, Serra Mauro Dalla, Macchi Paolo, Conti Luciano, Baudet Marie-Laure, Mansy Sheref S
Department CIBIO, University of Trento, via Sommarive 9, 38123 Povo, Italy.
National Research Council-Institute of Biophysics & Bruno Kessler Foundation, via alla Cascata 56/C, 38123 Trento, Italy.
Sci Adv. 2020 Sep 18;6(38). doi: 10.1126/sciadv.abb4920. Print 2020 Sep.
We report the construction of artificial cells that chemically communicate with mammalian cells under physiological conditions. The artificial cells respond to the presence of a small molecule in the environment by synthesizing and releasing a potent protein signal, brain-derived neurotrophic factor. Genetically controlled artificial cells communicate with engineered human embryonic kidney cells and murine neural stem cells. The data suggest that artificial cells are a versatile chassis for the in situ synthesis and on-demand release of chemical signals that elicit desired phenotypic changes of eukaryotic cells, including neuronal differentiation. In the future, artificial cells could be engineered to go beyond the capabilities of typical smart drug delivery vehicles by synthesizing and delivering specific therapeutic molecules tailored to distinct physiological conditions.
我们报道了在生理条件下与哺乳动物细胞进行化学通讯的人工细胞的构建。人工细胞通过合成并释放一种强效蛋白信号——脑源性神经营养因子,对环境中一种小分子的存在做出反应。基因控制的人工细胞与工程化的人胚肾细胞和小鼠神经干细胞进行通讯。数据表明,人工细胞是用于原位合成和按需释放化学信号的通用底盘,这些化学信号可引发真核细胞的所需表型变化,包括神经元分化。未来,通过合成和递送针对不同生理条件定制的特定治疗分子,人工细胞可被设计成超越典型智能药物递送载体的功能。